ArticleNPJ breast cancer2022

Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer.

Rachel Yoder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.